Skip to main content
Scripbox Logo
fund-logo

Tata India Pharma & Healthcare Fund (Growth)

Returns (1yr)
50.43 %
Latest NAV
13.35

Investment Calculator

  • Tenure
  • Returns %
  • Step Up %
Total Investment
Wealth Gained
Total Corpus Created
fund icon
Long Term Wealth
Inflation Beating Returns

Fund Information

as on 11th of August, 07:03 PM

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However,there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

Fund Managers

  • profile-pic
    Meeta Shetty
    profile-pic
    Rahul Singh
    profile-pic
    Sailesh Jain
  • expense-ratio
    Expense Ratio
    2.41
    benchmark
    Benchmark
    IISL Nifty Pharma TR INR
  • Aum image
    AUM
    ₹ 272.79 Crores
    ISIN
    ISIN
    INF277K016A9
  • Category Risk:

    High Risk

Holding Information

as on 11th of August, 07:03 PM

Top Holding

Sun Pharmaceuticals Industries Ltd
17%
Dr Reddy's Laboratories Ltd
16%
Divi's Laboratories Ltd
10%
Lupin Ltd
8%
Ipca Laboratories Ltd
7%

Top Sectors

Healthcare
98%

Allocation

Equity
98%
Others
2%
Debt
0%

Investment Return Calculator

as on 11th of August, 07:03 PM
  • Of
  • For
Total Corpus
Gains
Annualized %
  • Savings Bank
  • Fixed Deposit
  • Gold
  • Property
  • PPF
  • EPF
  • Mutual Fund(Equity)

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully. Past performance is not an indicator of future returns.

Transaction

as on 11th of August, 07:03 PM
Minimum SIP Amount
1000
Minimum Lumpsum Amount
5000
Lumpsum Multiple
100
SIP Multiple
100

About the Fund

Tata India Pharma & Healthcare Fund Regular Growth is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 0.0% over a period of 5 years. The fund is managed by Tata Asset Management Limited. The fund managers names are Meeta Shetty, Rahul Singh, Sailesh Jain. The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However,there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. The fund charges 2.41000%. The minimum SIP amount for this is ₹1000. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000.

Disclaimer: Scripbox has taken due care and caution in compilation of the data contained in this factsheet. This data has been obtained by Scripbox from sources which it considers reliable. However, please verify the data from the mutual fund company before taking any Investment action based on this information.